Hence the present study is targeting PNKP inhibition in combination with C-ion radiation to enhance the cell killing in radioresistant prostate cancer cell line PC-3.PNKP inhibition may be a promising approach to enhance clinical outcome of C-ion radiation in radioresistant cancer cells. This evidence concerns the gene PNKP and cancer.